Amplion
  • SOLUTIONS
    • MARKETING
    • SALES
    • BUSINESS DEVELOPMENT
  • WORKFLOWS
    • MARKETING
    • SALES
  • ABOUT
    • OUR DATA
    • WHY AMPLION?
    • CUSTOMER SUCCESS
  • GET A DEMO

  •  LOGIN
Select Page

Chart of the Week: Panels Emerging, Single Biomarker Tests Dominate

Jun 14, 2016 | Biomarkers, News

For the chart of the week we wanted to explore the market for multi-analyte panels.  We found that single biomarker tests still vastly outnumber panels.  Stay tuned for more trending information in the coming weeks.  My hypothesis: Panels, even outside of NGS, are...

Chart of the Week: Personalized Medicine Dependent on Time to Market

Apr 12, 2016 | News

In a CotW a few weeks ago we postulated that based on biomarker discovery work Celgene is poised to dominate personalized medicine.  However, this week’s chart suggests that if Celgene’s rise in personalized medicine is to happen it could be a long ways...

Amplion adds 10,165 LDTs to BiomarkerBase from almost all LDT developers: addition could be most comprehensive coverage of LDTs available.

Apr 12, 2016 | News

In mid-2015 we worked hard to add a new source of evidence for biomarkers: Laboratory Developed Tests, or LDTs.  This was a huge milestone for Amplion.  We successfully used our technology to identify biomarkers in a new information source very quickly without...

Chart of the Week: Innovative Biopharma = Faster Biomarkers to Trial

Apr 6, 2016 | News

A few months ago we investigated the use of unique biomarkers by big biopharma.  The use of unique biomarkers served as a measure of innovation for each of the biggest biopharma companies.  The most innovative companies are progressing biomarkers to trials more...

EUDAMED Access and LDT Uncertainty Threatens Personalized Medicine

Apr 4, 2016 | News

At Amplion we have a commercial interest in access to high quality clinical information that can inform and contribute to our flagship product, BiomarkerBase.  However, we are truly passionate about contributing to higher quality, more personalized, medical...
« Older Entries
Next Entries »
Precision Medicine Intelligence Platform
GET A DEMO
LOGIN

SOLUTIONS

Sales

Marketing

Business Development

RESOURCES

Marketing Workflows

Sales Workflows

Territory Sales Case Study

Global Sales Case Study

Life Science ABM Blog

COMPANY
About Us

Leadership

Investors

Careers

Copyright 2022 Amplion    |     Terms & Conditions    |    Privacy Policy    |    GDPR Guidance

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT